The critical appraisal of cost-effectiveness by health care payers and their nominated agencies have applied pressure on health care developers to review health economics and outcomes research (HEOR) earlier in their clinical development plans to gain optimal pricing and reimbursement.
At Axcellant, our team have supported organisations navigate through the UK National Institute of Clinical Excellence (NICE) Health Technology Assessment (HTA). We have also supported pricing and reimbursement research commissioned by the French Ministry of Health and Social Affairs and also modelling for agencies in the US and Asia.
Our skilled team of professionals brings together a wealth of experience garnered over numerous successful projects
We provide clarity where there is ambiguity and find opportunities when there is uncertainty.
Our operations team have broad and deep insights in the local ethics and regulatory framework.
We appreciate data is our common currency for a range of eventualities.
Our regulatory team masterfully apply critical thinking when defining the regulatory strategy.
Our systems, processes and training have been developed with a quality by design approach.